Skip to main content

COPD Set to Reach About 600 Million Cases Worldwide by 2050

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 12, 2023.

By Elana Gotkine HealthDay Reporter

MONDAY, Dec. 11, 2023 -- The prevalence of chronic obstructive pulmonary disease (COPD) is projected to continue increasing through 2050, approaching 600 million patients with COPD globally by 2050, according to a study published online Dec. 7 in JAMA Network Open.

Elroy Boers, Ph.D., from ResMed Science Center in Halifax, Nova Scotia, Canada, and colleagues conducted a modeling study to examine the global burden of COPD through 2050 considering COPD risk factors. Generalized additive models were developed, which included smoking prevalence, indoor and outdoor air pollution, and development indices as predictors to project global COPD prevalence.

The researchers estimate that from 2020 to 2050, the number of COPD cases will increase by 23 percent globally among those aged 25 years and older, approaching 600 million patients with COPD globally by 2050. The growth in COPD burden was projected to be largest among women and in low- and middle-income regions. By 2050, the number of cases in women was projected to increase by 47.1 percent compared with a 9.4 percent increase in men, and the number of cases in low- and middle-income regions was projected to be more than double that of high-income regions.

"Further research, prevention, and advocacy is needed to address these issues so that adequate preparation and resource allocation can take place," the authors write.

Several authors disclosed ties to ResMed, which funded the study.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

ACG: 2000 to 2022 Saw Rise in Early-Onset CRC Mortality in the United States

THURSDAY, Oct. 31, 2024 -- Early-onset colorectal cancer (EO-CRC) mortality rose in the United States over the past two decades, most notably in patients aged 20 to 44 years...

Cell-Free Blood DNA Tests Less Effective Than Other CRC Screening

WEDNESDAY, Oct. 30, 2024 -- Cell-free DNA blood tests (cf-bDNA) may be more costly and less effective for colorectal cancer (CRC) screening than other screening modalities...

American College of Surgeons, Oct. 19-22

The annual meeting of the American College of Surgeons was held this year from Oct. 19 to 22 in San Francisco and attracted participants from around the world, including...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.